Gene · 4739
Papers2,045
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,045
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying neuroanatomical and behavioral features for autism spectrum disorder diagnosis in children using machine learning. | PLoS One | 2022 | 35797364 | PubTator, text mining | PubMed |
| A time-resolved, multi-symbol molecular recorder via sequential genome editing. | Nature | 2022 | 35794474 | PubTator, text mining | PubMed |
| The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research. | Front Pharmacol | 2022 | 35784761 | PubTator, text mining | PubMed |
| Complement C1QC as a potential prognostic marker and therapeutic target in colon carcinoma based on single-cell RNA sequencing and immunohistochemical analysis. | Bosn J Basic Med Sci | 2022 | 35765947 | PubTator, text mining | PubMed |
| miR-4735-3p inhibits cell migration and invasion of gastric cancer by downregulating NEDD9. | Oncol Lett | 2022 | 35765282 | PubTator, text mining | PubMed |
| Trait Versus State Predictors of Emotional Distress Symptoms: The Role of the Big-5 Personality Traits, Metacognitive Beliefs, and Strategies. | J Nerv Ment Dis | 2022 | 35764593 | PubTator, text mining | PubMed |
| LncRNA HAR1A Suppresses the Development of Non-Small Cell Lung Cancer by Inactivating the STAT3 Pathway. | Cancers (Basel) | 2022 | 35740511 | PubTator, text mining | PubMed |
| Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder. | Biomedicines | 2022 | 35740379 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor Receptor Superfamily Member 21 Induces Endothelial-Mesenchymal Transition in Coronary Artery Endothelium of Type 2 Diabetes Mellitus. | Biomedicines | 2022 | 35740304 | PubTator, text mining | PubMed |
| The Transcriptome Profile of Retinal Pigment Epithelium and Müller Cell Lines Protected by Risuteganib Against Hydrogen Peroxide Stress. | J Ocul Pharmacol Ther | 2022 | 35731128 | PubTator, text mining | PubMed |
| Long Noncoding RNA LINC00467: Role in Various Human Cancers. | Front Genet | 2022 | 35719391 | PubTator, text mining | PubMed |
| CRISPR/Cas9 a simple, inexpensive and effective technique for gene editing. | Mol Biol Rep | 2022 | 35716290 | PubTator, text mining | PubMed |
| TRAF4 Inhibits the Apoptosis and Promotes the Proliferation of Breast Cancer Cells by Inhibiting the Ubiquitination of Spindle Assembly-Associated Protein Eg5. | Front Oncol | 2022 | 35692762 | PubTator, text mining | PubMed |
| Investigating the Genomic Background of CRISPR-Cas Genomes for CRISPR-Based Antimicrobials. | Evol Bioinform Online | 2022 | 35692726 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Connections for Matters of the Heart: Network Medicine in Cardiovascular Diseases. | Front Cardiovasc Med | 2022 | 35665246 | PubTator, text mining | PubMed |
| Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis. | Sci Rep | 2022 | 35650387 | PubTator, text mining | PubMed |
| Pathophysiology of Primary Cilia: Signaling and Proteostasis Regulation. | Front Cell Dev Biol | 2022 | 35646931 | PubTator, text mining | PubMed |
| Scalable biological signal recording in mammalian cells using Cas12a base editors. | Nat Chem Biol | 2022 | 35637351 | PubTator, text mining | PubMed |
| Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction. | Int J Mol Sci | 2022 | 35628196 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4739/papers?page=18